From ESC: Remote Monitoring for Atrial Fibrillation, Semaglutide and Tirzepatide in Patients With Heart Failure With Preserved Ejection Fraction, RSV Vaccine to Prevent Hospitalizations in Older Adults, and more
JAMA Editors' Summary
00:00
Comparison of GLP-1 Receptor Agonists in Heart Failure Treatment
This chapter explores a JAMA study evaluating the effectiveness of semaglutide and tirzepatide in heart failure patients with preserved ejection fraction. Through observational data emulation of randomized trials, the findings reveal no significant difference in reducing hospitalization and mortality risks compared to a placebo, sparking discussion on the reliability of such clinical trial emulations.
Transcript
Play full episode
